As Merck prepares to release its fourth-quarter results, investors are watching to see if the pharmaceutical leader can maintain its track record of exceeding expectations amid a slowing growth outlook.
Chipotle Mexican Grill is set to report its latest quarterly results Tuesday afternoon, with investors watching closely for signs of resilience in consumer spending and operational execution against a backdrop of moderating sales growth.
Investment firm Tanager Wealth Management has fully divested its position in Centessa Pharmaceuticals, capitalizing on the biotech's near-60% annual surge. The move highlights strategic portfolio rebalancing as the stock's rally potentially amplified its risk profile within a diversified fund.
After years of sluggish sales and brand challenges, Starbucks is betting on a dual strategy: deploying AI to streamline operations while reinvesting in the in-store experience. CEO Brian Niccol outlines the plan he believes will restore growth and community connection.
Despite a sharp 22% drop in cocoa sales volume and multi-year lows in cocoa futures, Barry Callebaut's (SWX:BARN) share price has rallied strongly. Analysts are divided on whether the current valuation reflects deep value or overlooks persistent headwinds in its core commodity business.
Shares of consumer goods giant Church & Dwight (CHD) climbed nearly 5% following the release of strong annual results and an optimistic sales forecast, coupled with its 30th consecutive annual dividend increase.
Dentsply Sirona faces mounting pressure as declining sales and poor capital returns challenge its recovery narrative. With shares down sharply over multiple years, investors question management's strategy in a competitive dental market.
Gulfport Energy (NYSE: GPOR) shares have surged roughly 200% over three years, yet a deep dive reveals conflicting signals. While a cash flow model suggests significant undervaluation, its price-to-sales ratio tells a more cautious tale, leaving investors to weigh the metrics against a volatile energy backdrop.
Despite a robust drug pipeline and steady long-term gains, AstraZeneca's recent share price stagnation has investors questioning its true worth. A deep dive into valuation models suggests the pharmaceutical giant may be trading at a significant discount to its intrinsic value, even as its P/E ratio appears elevated compared to peers.
Extreme Networks reports Q2 revenue of $317.9M and net income of $7.9M, while launching an AI-integrated partner initiative aimed at streamlining sales and driving higher-margin software revenue.
Facing softer demand and tariff volatility, Minerals Technologies (MTX) reported steady 2025 sales of $2.1B but saw margins contract. Leadership emphasized cost discipline and safety while detailing a series of expansion projects poised to drive a meaningful rebound in the coming year.
Littelfuse shares rallied sharply following the closure of its Basler Electric acquisition, alongside stronger-than-expected Q1 2026 sales guidance and a new dividend declaration, despite posting a significant net loss for Q4 2025.
Marketing technology firm Zeta Global announces a strategic collaboration with OpenAI, aiming to deeply integrate advanced AI into its platform. The move, coupled with positive buzz from CES 2026, sharpens its competitive edge in a sector dominated by giants like Salesforce and Adobe.
Specialty metals maker Carpenter Technology posted record Q2 sales and raised its full-year operating income outlook, yet its stock fell sharply. The divergence highlights investor concerns over valuation and the company's heavy dependence on the aerospace cycle, even as demand in the sector remains robust.
As cocoa futures pull back from historic highs, Morgan Stanley boosts its price target for snack giant Mondelez International, citing improved earnings visibility. The firm maintains an Overweight rating, highlighting the company's resilient financials and shareholder returns amidst lingering sales growth uncertainties.
U.S. wheat futures declined across major exchanges on Friday, with Chicago, Kansas City, and Minneapolis contracts all trading lower. Despite the pullback, export sales data remains robust, running ahead of last year's pace.
Soybean prices extended their decline on Friday, pressured by lackluster export sales data and a broader commodity sell-off. With key commitments lagging last year's pace, traders are now looking ahead to next week's crush data for signs of domestic demand strength.
Corn futures extended losses on Friday, pressured by a strengthening U.S. dollar and weaker crude oil prices. Despite robust export sales data running ahead of historical pace, front-month contracts fell 5 to 5.5 cents, pushing the national average cash price lower.
Peter McGuinness, the CEO who sought to reposition plant-based meat for mainstream consumers by moving beyond climate messaging, is departing Impossible Foods. His exit comes as the broader alternative protein sector faces significant sales declines and strategic recalibration.
DXC Technology met Q4 revenue targets with stable sales of $3.19B and an earnings surprise, but cautious guidance and stagnant organic growth highlight the challenges of its strategic transformation toward AI-native services.
